Literature DB >> 22303870

Characteristic features of stem cells in glioblastomas: from cellular biology to genetics.

Mark J Knights1, Stuart Kyle, Azzam Ismail.   

Abstract

Glioblastoma is the most common type of primary brain tumor in adults and is among the most lethal and least successfully treated solid tumors. Recently, research into the area of stem cells in brain tumors has gained momentum. However, due to the relatively new and novel hypothesis that a subpopulation of cancer cells in each malignancy has the potential for tumor initiation and repopulation, the data in this area of research are still in its infancy. This review article is aimed at attempting to bring together research carried out so far in order to build an understanding of glioblastoma stem cells (GSCs). Initially, we consider GSCs at a morphological and cellular level, and then discuss important cell markers, signaling pathways and genetics. Furthermore, we highlight the difficulties associated with what some of the evidence indicates and what collectively the studies contribute to further defining the interpretation of GSCs.
© 2012 The Authors; Brain Pathology © 2012 International Society of Neuropathology.

Entities:  

Mesh:

Year:  2012        PMID: 22303870     DOI: 10.1111/j.1750-3639.2012.00573.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  4 in total

1.  CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.

Authors:  Alonso Barrantes-Freer; Mirjam Renovanz; Marcus Eich; Alina Braukmann; Bettina Sprang; Pavel Spirin; Luis A Pardo; Alf Giese; Ella L Kim
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

2.  Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules.

Authors:  Anne Clavreul; Angélique Montagu; Anne-Laure Lainé; Clément Tétaud; Nolwenn Lautram; Florence Franconi; Catherine Passirani; Anne Vessières; Claudia N Montero-Menei; Philippe Menei
Journal:  Int J Nanomedicine       Date:  2015-02-12

3.  EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis.

Authors:  Krishna M Talasila; Anke Soentgerath; Philipp Euskirchen; Gro V Rosland; Jian Wang; Peter C Huszthy; Lars Prestegarden; Kai Ove Skaftnesmo; Per Øystein Sakariassen; Eskil Eskilsson; Daniel Stieber; Olivier Keunen; Narve Brekka; Ingrid Moen; Janice M Nigro; Olav K Vintermyr; Morten Lund-Johansen; Simone Niclou; Sverre J Mørk; Per Oyvind Enger; Rolf Bjerkvig; Hrvoje Miletic
Journal:  Acta Neuropathol       Date:  2013-02-22       Impact factor: 17.088

4.  Medullospheres from DAOY, UW228 and ONS-76 cells: increased stem cell population and proteomic modifications.

Authors:  Cristina Zanini; Elisabetta Ercole; Giorgia Mandili; Roberta Salaroli; Alice Poli; Cristiano Renna; Valentina Papa; Giovanna Cenacchi; Marco Forni
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.